This discussion reviews the role of SAVR/TAVR compared to CS on clinical outcomes for patients with asymptomatic severe aortic stenosis (AS), evaluating the potential benefits and challenges of performing AVR intervention in asymptomatic AS patients. Faculty discuss clinical outcomes based on data from randomized controlled trials and meta-analysis findings, explore emerging data suggesting improved survival and lower rates of unplanned cardiovascular or heart failure-related hospitalizations and stroke when patients undergo AVR compared to CS, and assess the benefits and challenges of AVR intervention using data from the recently published systematic review article. Read the article in JSCAI here: https://www.jscai.org/article/S2772-9303(25)01105-6/fulltext
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Member | Free |
| Non-Member | $19 |
| Fellow-In-Training | Free |
| Cardio Team Member | Free |
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 0.25 credits
- MOC · Up to 0.25 points
- Commercial Support
-
ReleasedApr 30, 2026
-
Last day to claim creditMay 1, 2029 3 years left
-
Society for Cardiovascular Angiography and Interventions, The SCAI 2026 The End of Watchful Waiting: Long Term TAVR Evidence and a New Proactive Paradigm
-
Society for Cardiovascular Angiography and Interventions, The SCAI Expert Consensus Statement on Alternative Access for Transcatheter Aortic Valve Replacement : Journal CME
-
Society for Cardiovascular Angiography and Interventions, The Conversations in Interventional Cardiology: Global Results from the Optimize PRO Study: Standardized TAVR Technique and Care Pathway
